"The Omicron variant of Covid-19, also known as the B.1.1.529 strain, is splashed all over the international headlines.
The new variant, which some claim is three times more contagious, was initially discovered in Botswana before it spread across South Africa.
The news was met with global alarm, prompting financial markets to plummet and new travel bans to be put in place.
According to a public statement by the Botswana government, the new mutation was first discovered in four people who had received both doses of the COVID-19 vaccine.
“The initial investigations on the virus have established that the new
variant has a high number of mutations as compared to the locally
predominant Delta variant,” the task force added.
Dr. Geert Vanden Bossche, a leading critic of an universal vaccination agenda that ignores natural immunity, is that the mRNA therapeutics being marketed as ‘vaccines’ may help fuel variants. He holds a DVM from the University of Ghent, Belgium, and a PhD degree in Virology from the University of Hohenheim, Germany. He has worked for several vaccine companies: GSK Biologicals, Novartis Vaccines, Solvay Biologicals. He has contributed to vaccine R&D as well as late vaccine development.
Vanden Bossche was hired by the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as a Senior Program Officer, before leaving to work with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. He was also a part of the German Center for Infection Research in Cologne as Head of the Vaccine Development Office.
“As of the early days of the mass vaccination campaigns, at least a
“This already explains why the WHO’s mass vaccination program is not only unable to generate herd immunity (HI) but even leads to substantial erosion of the population’s immune protective capacity,” he goes on. As the ongoing universal mass vaccination program will soon promote dominant propagation of highly infectious, neutralization escape mutants (i.e., so-called ‘S Ab-resistant variants’), naturally acquired, or vaccinal neutralizing Abs, will, indeed, no longer offer any protection to immunized individuals whereas high infectious pressure will continue to suppress the innate immune defense system of the nonvaccinated.”
“This is to say that every further increase in vaccine coverage rates will further contribute to forcing the virus into resistance to neutralizing, S-specific Abs,” he continued. “Increased viral infectivity, combined with evasion from antiviral immunity, will inevitably result in an additional toll taken on human health and human lives.”
“Immediate
action needs, therefore, to be taken in order to dramatically reduce
viral infectivity rates and to prevent selected immune escape variants
from rapidly spreading through the entire population, whether vaccinated
or not,” he adds. “This first critical step can only be achieved by
calling an immediate halt to the mass vaccination program and replacing
it by widespread use of antiviral chemoprophylactics while dedicating
massive public health resources to scaling early multidrug treatments of
Covid-19 disease.” TP/SummitNews
